| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,021,000 | 1,301,000 | 1,335,000 | 1,301,000 | | Cost of Revenue | (361,000) | 485,000 | 334,000 | (168,000) | | | Gross Profit | 1,382,000 | 816,000 | 1,001,000 | 1,469,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,070,000 | 229,000 | 404,000 | 882,000 | | Non Recurring | 27,000 |
-
|
-
|
-
| | Others | (109,000) | 192,000 | 39,000 | 38,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 394,000 | 395,000 | 558,000 | 549,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 394,000 | 395,000 | 558,000 | 549,000 | | Interest Expense | 59,000 | 40,000 | 51,000 | 50,000 | | Income Before Tax | 335,000 | 355,000 | 507,000 | 499,000 | | Income Tax Expense | 130,000 | 137,000 | 199,000 | 195,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 205,000 | 218,000 | 308,000 | 304,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 205,000 | 218,000 | 308,000 | 304,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $205,000 | $218,000 | $308,000 | $304,000 |
|
2.03% Nasdaq 0.00%
Income Statement
